Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-2'h-spiro(cyclohexane-1,3'-imidazo(1,5-a)pyridine)-1',5'-dione
2. Eft508
3. Spiro(cyclohexane-1,3'(2'h)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-
1. Eft508
2. 1849590-01-7
3. Eft-508
4. Tomivosertib [inn]
5. Tomivosertib [usan]
6. Eft 508
7. U2h19x4wbv
8. Chembl4073443
9. 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'h-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'h)-dione
10. 6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2h-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione
11. Eft508 Hcl
12. 6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2'h-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione
13. Spiro(cyclohexane-1,3'(2'h)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-
14. Eft508; Tomivosertib
15. Tomivosertib (usan/inn)
16. Tomivosertib [usan:inn]
17. Eft-508 Hcl
18. Unii-u2h19x4wbv
19. Tomivosertib [who-dd]
20. Schembl17362622
21. Gtpl10167
22. Eft-508 (eft508)
23. Dtxsid601022534
24. Bcp18993
25. Ex-a2494
26. Bdbm50263263
27. Nsc791783
28. Nsc791784
29. Nsc804952
30. Zinc575623807
31. Ccg-267922
32. Cs-5841
33. Db15219
34. Nsc-791783
35. Nsc-791784
36. Nsc-804952
37. Compound 23 [pmid: 29526098]
38. Ncgc00492296-03
39. Ac-35882
40. Be168437
41. Bs-16162
42. Hy-100022
43. S8275
44. D11452
45. D71143
46. A902706
47. 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'hspiro(cyclohexane-1,3'-imidazo(1,5-a)pyridine)-1',5'-dione
48. N45
Molecular Weight | 340.4 g/mol |
---|---|
Molecular Formula | C17H20N6O2 |
XLogP3 | 1.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 340.16477390 g/mol |
Monoisotopic Mass | 340.16477390 g/mol |
Topological Polar Surface Area | 113 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 664 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
30
PharmaCompass offers a list of Tomivosertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tomivosertib manufacturer or Tomivosertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tomivosertib manufacturer or Tomivosertib supplier.
PharmaCompass also assists you with knowing the Tomivosertib API Price utilized in the formulation of products. Tomivosertib API Price is not always fixed or binding as the Tomivosertib Price is obtained through a variety of data sources. The Tomivosertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tomivosertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tomivosertib, including repackagers and relabelers. The FDA regulates Tomivosertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tomivosertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tomivosertib supplier is an individual or a company that provides Tomivosertib active pharmaceutical ingredient (API) or Tomivosertib finished formulations upon request. The Tomivosertib suppliers may include Tomivosertib API manufacturers, exporters, distributors and traders.
Tomivosertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tomivosertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tomivosertib GMP manufacturer or Tomivosertib GMP API supplier for your needs.
A Tomivosertib CoA (Certificate of Analysis) is a formal document that attests to Tomivosertib's compliance with Tomivosertib specifications and serves as a tool for batch-level quality control.
Tomivosertib CoA mostly includes findings from lab analyses of a specific batch. For each Tomivosertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tomivosertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Tomivosertib EP), Tomivosertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tomivosertib USP).